September 27, 2010
Beyaz oral contraceptive that raises folate levels approved
Beyaz is approved for the prevention of pregnancy, treatment of symptoms of premenstrual dysphoric disorder (PMDD), treatment of moderate acne for women at ≥14 years of age who have started having menstrual periods, and to raise folate levels in women who choose oral contraceptives for birth control for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.
Beyaz is a 24/4 day regimen consisting of 24 days of drospirenone 3mg/ethinyl estradiol 20mcg/levomefolate calcium (Metafolin) 451mcg followed by four days of Metafolin only. Beyaz is expected to be available in October 2010.
For more information call (877) 745-5855 or visit www.beyaz.com.